Evidence map›Paper›PMID 38355197›Full record

ArticleBMJ open2024

Investigating experiences of people with advanced breast or lung cancer in their natural context: protocol for an experience sampling study.

Joran Geeraerts, Lara Pivodic, Kim De Nooijer, Eline Naert, Geert Crombez, Mark De Ridder, Lieve Van den Block

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. A comparison of in-the-moment and retrospective patient-reported outcome measures in advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joran GeeraertsEnd-of-Life Care Research Group, Vrije Universiteit Brussel, Brussel, Belgium joran.geeraerts@vub.be.ORCID 0000-0001-5658-5544
Lara PivodicEnd-of-Life Care Research Group, Vrije Universiteit Brussel, Brussel, Belgium.ORCID 0000-0002-8825-3699
Kim De NooijerEnd-of-Life Care Research Group, Vrije Universiteit Brussel, Brussel, Belgium.ORCID 0000-0003-2887-6832
Eline NaertDepartment of Medical Oncology, UZ Gent, Gent, Belgium.
Geert CrombezDepartment of Experimental Clinical and Health Psychology, University of Ghent, Gent, Belgium.
Mark De RidderTranslational Radiation Oncology, Physics and Supportive Care Research Group, Vrije Universiteit Brussel, Brussel, Belgium.
Lieve Van den BlockEnd-of-Life Care Research Group, Vrije Universiteit Brussel, Brussel, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople with advanced cancer can experience a wide range of multidimensional symptoms or concerns, but little is known about when and how these fluctuate in daily life. Experience sampling methods (ESMs) involve repeated self-reports in people's natural contexts aimed at uncovering everyday life experiences. ESM has limited recall bias and good ecological validity but might be burdensome to patients. This study aims to pretest and evaluate the feasibility and clinical utility of a validated ESM and use it to explore everyday experiences of people living with advanced breast or lung cancer. METHODS AND ANALYSIS: In step 1, we will optimise our ESM method by pretesting it through usability interviews and a pilot ESM study. In step 2, we will evaluate and use the ESM method through an observational ESM study to investigate the daily experiences of people with advanced breast or lung cancer. Step 2 also includes interviews with healthcare professionals to determine the clinical utility of ESM in oncology. Participants will complete a digital questionnaire ten times per day, measuring momentary experiences in the physical, psychological, social, spiritual-existential domains and context. Multilevel regression models will analyse fluctuations and temporal relations among measured experiences and context. Analyses also include evaluation of compliance and participation rates. We will apply content analysis to the usability interviews and follow-up interviews of the pilot ESM study. ETHICS AND DISSEMINATION: We obtained approval from the ethics committees of the University Hospitals of Brussels (BUN: 1432023000043) and Ghent (ONZ-2023-0136). Results will be published in open-access, peer-reviewed journals and presented at conferences. If ESM appears feasible in this population, it could offer new insights into the daily experiences and help optimise support for people with advanced cancer.

Indexed as

Ecological Momentary AssessmentLung NeoplasmsFeasibility StudiesHumansSelf ReportSurveys and QuestionnairesONCOLOGYQuality of LifeTelemedicine

Identifiers

PMID38355197
PMCPMC10868311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.